The work of the Human Immunome Project is spearheaded by our global network of staff and consultants and supported by members of our Board of Directors and advisory committees. Together with our partners and supporters, we are championing the mission of HIP and overseeing a global consortium to generate diverse immunological data at scale and build publicly available AI models of the human immune system.
Founding General Partner, Humain Ventures; 23andMe
Jose-Maria Fernandez
Former Director General, Spanish Treasury
Ian Gust, AO, MD, Board Emeritus
University of Melbourne
Kenneth Holroyd, MD
Vanderbilt University Medical Center
Hans Keirstead, PhD
Human Immunome Project
Robert Klein
Klein Financial Corporation
Marie-Paule Kieny, PhD, Board Emeritus
Institut National de la Sante et la Recherche Medicale (INSERM)
Neema Mgana, PhD
United Nations
Stanley Plotkin, MD, Board Emeritus
University of Pennsylvania, Vaxconsult
Rey Ramsey
CEO, Nathan Cummings Foundation, Centri Capital
Douglas Richman, MD
University of California, San Diego
The Human Immunome Project has established advisory committees to help guide its work and inform decision-making. Comprised of subject matter experts, the HIP advisory committees offer independent expertise, global experience, and support in delivering on HIP’s mission.